Example: Heart Attack

Clinical Trials Sponsored by CytoVac A/S

Total 7 results

NCT02799238

Completed

Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma

Conditions: Glioblastoma
NCT02060955

Terminated

Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan

Conditions: Glioblastoma Multiforme
NCT01984658

Completed

A Prospective, Open Phase I Study to Investigate the Tolerability and Efficacy of ALECSAT to Pancreas Cancer Patients

Conditions: Pancreatic Cancer
NCT01588769

Completed

A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients

Conditions: Glioblastoma Multiforme
NCT01422850

Completed

Safety Study of Repeated Dosing of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy

Conditions: Hormone-refractory Prostate Cancer
NCT00891345

Completed

Safety Study of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy

Conditions: Hormone-refractory Prostate Cancer
NCT04609215

Recruiting

ImmunoBreast - A Phase Ib Study

Conditions: Triple Negative Breast Cancer; Breast Cancer; Metastatic Breast Cancer